Literature DB >> 17332370

High levels of heat shock protein Hsp72 in cancer cells suppress default senescence pathways.

Julia A Yaglom1, Vladimir L Gabai, Michael Y Sherman.   

Abstract

The major heat shock protein Hsp72 is constitutively expressed in many tumor cell lines and biopsies, and its expression correlates with poor prognosis in several types of cancer. Hsp72 was suggested to play an important role in neoplastic transformation and tumor development. We addressed the role of Hsp72 in cancer cells by investigating the consequences of specific depletion of Hsp72 using small interfering RNA. Down-regulation of Hsp72 in certain cancer lines triggered cell senescence associated with activation and stabilization of p53 and induction of the cell cycle inhibitor p21. Effects of Hsp72 depletion on senescence and p53 did not result from a proteotoxic stress, DNA instability, or activation of ataxia-telangiectasia-mutated (ATM) and ATM- and Rad3-related pathways. Instead, depletion of Hsp72 reduced stability and activity of the p53 inhibitor Hdm2. In addition, Hsp72 depletion triggered a p53-independent senescence program through inhibitory phosphorylation and down-regulation of the cell cycle kinase Cdc2. Therefore, Hsp72 provides a selective advantage to cancer cells by suppressing default senescence via p53-dependent and p53-independent pathways.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17332370     DOI: 10.1158/0008-5472.CAN-06-3796

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  48 in total

1.  Effects of temozolomide (TMZ) on the expression and interaction of heat shock proteins (HSPs) and DNA repair proteins in human malignant glioma cells.

Authors:  Gisela Natalia Castro; Niubys Cayado-Gutiérrez; Felipe Carlos Martín Zoppino; Mariel Andrea Fanelli; Fernando Darío Cuello-Carrión; Mayra Sottile; Silvina Beatriz Nadin; Daniel Ramón Ciocca
Journal:  Cell Stress Chaperones       Date:  2014-08-26       Impact factor: 3.667

Review 2.  The human HSP70 family of chaperones: where do we stand?

Authors:  Jürgen Radons
Journal:  Cell Stress Chaperones       Date:  2016-02-10       Impact factor: 3.667

Review 3.  Heat shock protein 70 (hsp70) as an emerging drug target.

Authors:  Christopher G Evans; Lyra Chang; Jason E Gestwicki
Journal:  J Med Chem       Date:  2010-06-24       Impact factor: 7.446

4.  Proteotoxicity is not the reason for the dependence of cancer cells on the major chaperone Hsp70.

Authors:  Teresa A Colvin; Vladimir L Gabai; Michael Y Sherman
Journal:  Cell Cycle       Date:  2014-06-09       Impact factor: 4.534

5.  Cellular senescence and protein degradation: breaking down cancer.

Authors:  Xavier Deschênes-Simard; Frédéric Lessard; Marie-France Gaumont-Leclerc; Nabeel Bardeesy; Gerardo Ferbeyre
Journal:  Cell Cycle       Date:  2014-05-27       Impact factor: 4.534

6.  Differential heat shock protein localization in chronic lymphocytic leukemia.

Authors:  Nina C Dempsey; Francesca Leoni; H Elyse Ireland; Christine Hoyle; John H H Williams
Journal:  J Leukoc Biol       Date:  2009-12-10       Impact factor: 4.962

7.  HLA complex-linked heat shock protein genes and childhood acute lymphoblastic leukemia susceptibility.

Authors:  Esma Ucisik-Akkaya; Charronne F Davis; Clara Gorodezky; Carmen Alaez; M Tevfik Dorak
Journal:  Cell Stress Chaperones       Date:  2009-12-09       Impact factor: 3.667

8.  Hsp70-Bag3 interactions regulate cancer-related signaling networks.

Authors:  Teresa A Colvin; Vladimir L Gabai; Jianlin Gong; Stuart K Calderwood; Hu Li; Suryaram Gummuluru; Olga N Matchuk; Svetlana G Smirnova; Nina V Orlova; Irina A Zamulaeva; Mikel Garcia-Marcos; Xiaokai Li; Z T Young; Jennifer N Rauch; Jason E Gestwicki; Shinichi Takayama; Michael Y Sherman
Journal:  Cancer Res       Date:  2014-07-03       Impact factor: 12.701

9.  Anticancer Effects of Targeting Hsp70 in Tumor Stromal Cells.

Authors:  Vladimir L Gabai; Julia A Yaglom; Yongmei Wang; Le Meng; Hao Shao; Geunwon Kim; Teresa Colvin; Jason Gestwicki; Michael Y Sherman
Journal:  Cancer Res       Date:  2016-08-08       Impact factor: 12.701

Review 10.  Pharmacological targeting of the Hsp70 chaperone.

Authors:  Srikanth Patury; Yoshinari Miyata; Jason E Gestwicki
Journal:  Curr Top Med Chem       Date:  2009       Impact factor: 3.295

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.